Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review

• Published in: Clinics (São Paulo, Brazil) Vol. 69; no. 4; pp. 271 - 278
• Main Authors: Sette, Luís Henrique Bezerra Cavalcanti, de Almeida Lopes, Edmundo Pessoa
• Format: Journal Article
• Language: English
• Published: Brazil Elsevier España, S.L.U 01-04-2014; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo; Faculdade de Medicina / USP; Elsevier España
• Subjects: Adult; Alanine Aminotransferase; Alanine Transaminase - blood; Aspartate Aminotransferase; Aspartate Aminotransferases - blood; Dialysis; Female; Gamma-Glutamyl Transferase; gamma-Glutamyltransferase - blood; Humans; Liver - enzymology; Male; MEDICINE, GENERAL & INTERNAL; Renal Dialysis; Renal Insufficiency, Chronic - blood; Renal Insufficiency, Chronic - enzymology; Renal Insufficiency, Chronic - therapy; Review; Time Factors; Transaminases; Gamma-Glutamyl Transferase; Aspartate Aminotransferase; Dialysis; Transaminases; Alanine Aminotransferase
• ISSN: 1807-5932; 1980-5322; 1980-5322
• DOI: 10.6061/clinics/2014(04)09

We reviewed the literature regarding the serum levels of the enzymes aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transferase in patients with chronic kidney disease on hemodialysis with and without viral hepatitis.
Original articles published up to January 2013 on adult patients with chronic kidney disease on hemodialysis were selected. These articles contained the words “transaminases” “aspartate aminotransferase” “alanine aminotransferase” “gamma glutamyl transferase,” “liver enzymes”, AND “dialysis” OR “hemodialysis”.
A total of 823 articles were retrieved. After applying the inclusion and exclusion criteria, 49 articles were selected. The patients with chronic kidney disease on hemodialysis had reduced serum levels of aminotransferases due to hemodilution, lower pyridoxine levels, or elevated homocysteine levels. The chronic kidney disease patients on hemodialysis infected with the hepatitis C virus also had lower aminotransferase levels compared with the infected patients without chronic kidney disease. This reduction is in part due to decreased viremia caused by the dialysis method, the production of a hepatocyte growth factor and endogenous interferon-α, and lymphocyte activation, which decreases viral action on hepatocytes. Few studies were retrieved on gamma-glutamyl transferase serum levels; those found reported that there were no differences between the patients with or without chronic kidney disease.
The serum aminotransferase levels were lower in the patients with chronic kidney disease on hemodialysis (with or without viral hepatitis) than in the patients with normal renal function; this reduction has a multifactorial origin.